Mitochondria and Mitochondrial Cascades in Alzheimer's Disease

Overview

Journal J Alzheimers Dis

Publisher Sage Publications

Specialties Geriatrics
Neurology

Date 2017 Oct 18

PMID 29036828

Citations 364

Authors

Russell H Swerdlow

Affiliations

Soon will be listed here.

Abstract

Decades of research indicate mitochondria from Alzheimer's disease (AD) patients differ from those of non-AD individuals. Initial studies revealed structural differences, and subsequent studies showed functional deficits. Observations of structure and function changes prompted investigators to consider the consequences, significance, and causes of AD-related mitochondrial dysfunction. Currently, extensive research argues mitochondria may mediate, drive, or contribute to a variety of AD pathologies. The perceived significance of these mitochondrial changes continues to grow, and many currently believe AD mitochondrial dysfunction represents a reasonable therapeutic target. Debate continues over the origin of AD mitochondrial changes. Some argue amyloid-β (Aβ) induces AD mitochondrial dysfunction, a view that does not challenge the amyloid cascade hypothesis and that may in fact help explain that hypothesis. Alternatively, data indicate mitochondrial dysfunction exists independent of Aβ, potentially lies upstream of Aβ deposition, and suggest a primary mitochondrial cascade hypothesis that assumes mitochondrial pathology hierarchically supersedes Aβ pathology. Mitochondria, therefore, appear at least to mediate or possibly even initiate pathologic molecular cascades in AD. This review considers studies and data that inform this area of AD research.

Citing Articles

The Intersection of Mitophagy and Autism Spectrum Disorder: A Systematic Review.

Kovacheva E, Gevezova M, Mehterov N, Kazakova M, Sarafian V Int J Mol Sci. 2025; 26(5).

PMID: 40076836 PMC: 11899999. DOI: 10.3390/ijms26052217.

Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease.

Al-Abbas N, Shaer N J Alzheimers Dis Rep. 2025; 8(1):1705-1721.

PMID: 40034366 PMC: 11863740. DOI: 10.1177/25424823241309024.

Identifying shared diagnostic genes and mechanisms in vascular dementia and Alzheimer's disease via bioinformatics and machine learning.

Zheng W, Lin D, Shi S, Ren J, Wu J, Wang M J Alzheimers Dis Rep. 2025; 8(1):1558-1572.

PMID: 40034343 PMC: 11863729. DOI: 10.1177/25424823241289804.

Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer's Disease in Down Syndrome.

Beresford-Webb J, McAllister C, Sleigh A, Walpert M, Holland A, Zaman S Brain Sci. 2025; 15(2).

PMID: 40002463 PMC: 11853603. DOI: 10.3390/brainsci15020130.

Mitochondrial Dysfunction in Neurodegenerative Diseases.

Yang H Cells. 2025; 14(4).

PMID: 39996748 PMC: 11853439. DOI: 10.3390/cells14040276.

References

Petersen C, Alikhani N, Behbahani H, Wiehager B, Pavlov P, Alafuzoff I . The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U S A. 2008; 105(35):13145-50. PMC: 2527349. DOI: 10.1073/pnas.0806192105. View

Roses A . An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. Arch Neurol. 2010; 67(5):536-41. PMC: 3140162. DOI: 10.1001/archneurol.2010.88. View

LaFerla F . Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci. 2002; 3(11):862-72. DOI: 10.1038/nrn960. View

Fernandez-Vizarra P, Fernandez A, Castro-Blanco S, Serrano J, Bentura M, Martinez-Murillo R . Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol Histopathol. 2004; 19(3):823-44. DOI: 10.14670/HH-19.823. View

Frackowiak R, Pozzilli C, Legg N, DU BOULAY G, Marshall J, Lenzi G . Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain. 1981; 104(Pt 4):753-78. DOI: 10.1093/brain/104.4.753. View

Parks J, Smith T, Trimmer P, Bennett Jr J, Parker Jr W . Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem. 2001; 76(4):1050-6. DOI: 10.1046/j.1471-4159.2001.00112.x. View

Mosconi L, Glodzik L, Mistur R, McHugh P, Rich K, Javier E . Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's. Biol Psychiatry. 2010; 68(10):913-21. PMC: 2967599. DOI: 10.1016/j.biopsych.2010.07.011. View

Askanas V, Engel W, Alvarez R . Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol. 1992; 141(1):31-6. PMC: 1886568. View

Swerdlow R . Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxid Redox Signal. 2011; 16(12):1434-55. PMC: 3329949. DOI: 10.1089/ars.2011.4149. View

10.

Bijur G, Davis R, Jope R . Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res Mol Brain Res. 1999; 71(1):69-77. DOI: 10.1016/s0169-328x(99)00168-0. View

11.

Onyango I, Bennett Jr J, Tuttle J . Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids. Neurobiol Dis. 2005; 19(1-2):312-22. DOI: 10.1016/j.nbd.2005.01.026. View

12.

Trimmer P, Borland M . Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. Antioxid Redox Signal. 2005; 7(9-10):1101-9. DOI: 10.1089/ars.2005.7.1101. View

13.

Canevari L, Clark J, Bates T . beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 1999; 457(1):131-4. DOI: 10.1016/s0014-5793(99)01028-5. View

14.

Wallace D . Mitochondrial genetics: a paradigm for aging and degenerative diseases?. Science. 1992; 256(5057):628-32. DOI: 10.1126/science.1533953. View

15.

Walsh D, Selkoe D . A beta oligomers - a decade of discovery. J Neurochem. 2007; 101(5):1172-84. DOI: 10.1111/j.1471-4159.2006.04426.x. View

16.

Khachaturian Z . Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview. Ann N Y Acad Sci. 1989; 568:1-4. DOI: 10.1111/j.1749-6632.1989.tb12485.x. View

17.

Johnson A, Blum N . Nucleoside phosphatase activities associated with the tangles and plaques of alzheimer's disease: a histochemical study of natural and experimental neurofibrillary tangles. J Neuropathol Exp Neurol. 1970; 29(3):463-78. DOI: 10.1097/00005072-197007000-00009. View

18.

Honea R, Swerdlow R, Vidoni E, Goodwin J, Burns J . Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology. 2010; 74(2):113-20. PMC: 2809030. DOI: 10.1212/WNL.0b013e3181c918cb. View

19.

Leuner K, Schutt T, Kurz C, Eckert S, Schiller C, Occhipinti A . Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal. 2012; 16(12):1421-33. PMC: 3329950. DOI: 10.1089/ars.2011.4173. View

20.

Gan X, Huang S, Wu L, Wang Y, Hu G, Li G . Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Biochim Biophys Acta. 2013; 1842(2):220-31. PMC: 3991235. DOI: 10.1016/j.bbadis.2013.11.009. View